FOI_8891

Internal Reference Number: FOI_8891

Date Request Received: 08/09/2025 00:00:00

Date Request Replied To: 17/09/2025 00:00:00

This response was sent via: By Email

Request Summary: Biologics Rheumatology

Request Category: Companies


Question Number 1: Could you please provide the numbers of patients treated by the rheumatology department (for any condition) in the last 3 months with the following drugs: Abatacept [Orencia] Adalimumab [Humira] Adalimumab Biosimilars Apremilast [Otezla] Baricitinib [Olumiant] Bimekizumab [Bimzelx] Certolizumab [Cimzia] Etanercept [Enbrel] Etanercept Biosimilars Filgotinib [Jyseleca] Golimumab [Simponi] Guselkumab [Tremfya] Infliximab [Remicade] Infliximab Biosimilars Ixekizumab [Taltz] Risankizumab [Skyrizi] Rituximab [MabThera] Rituximab Biosimilars Sarilumab [Kevzara] Secukinumab [Cosentyx] Tocilizumab [Ro Actemra] Tocilizumab Biosimilars Tofacitinib [Xeljanz] Upadacitinib [Rinvoq] Ustekinumab [Stelara] Ustekinumab Biosimilar

Answer To Question 1: Please see our response to all questions in the file attached. To accompany this answer to question 1 please also see the documents listed below: 13237 - FOI_8891 - Biologics Rheumatology - FOR ISSUE.xlsx

Question Number 2: Could you please provide the numbers of patients treated for Psoriatic Arthritis (PsA) ONLY in the last 3 months with the following drugs. Abatacept [Orencia] Adalimumab [Humira] Adalimumab Biosimilars Apremilast [Otezla] Bimekizumab [Bimzelx] Certolizumab [Cimzia] Etanercept [Enbrel] Etanercept Biosimilars Golimumab [Simponi] Guselkumab [Tremfya] Infliximab [Remicade] Infliximab Biosimilars Ixekizumab [Taltz] Risankizumab [Skyrizi] Secukinumab [Cosentyx] Tofacitinib [Xeljanz] Upadacitinib [Rinvoq] Ustekinumab [Stelara] Ustekinumab Biosimilar

Answer To Question 2: Please see our response to all questions in the file attached.
Please see Attachments:


To return to the list of all the FOI requests please click here

Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.